Viewing Study NCT00024661


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-01 @ 5:20 AM
Study NCT ID: NCT00024661
Status: COMPLETED
Last Update Posted: 2011-04-13
First Post: 2001-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
Sponsor: INSYS Therapeutics Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-03
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2004-10
Completion Date Type: None
First Submit Date: 2001-09-24
First Submit QC Date: None
Study First Post Date: 2001-09-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-04-12
Last Update Post Date: 2011-04-13
Last Update Post Date Type: ESTIMATED